Comparative study between neoadjuvant hormone therapy plus CDK-4/6 inhibitors versus neoadjuvant chemotherapy for hormone receptor–positive breast cancer patients.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Author: Nashi Semitha
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7162684854
Cites:
Cited by:
Related to: